Sabrina Malhi

Sabrina Malhi is a national health-care reporter based in Washington, D.C., covering breaking news and issues related to infant and maternal health. She has a master's degree in journalism from New York University and a bachelor's degree in English from the University at Buffalo.

72%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

86%

Examples:

  • Biases found in reporting on meningitis and dengue fever.
  • Disproportionate representation of African Americans as a risk factor for meningitis.

Conflicts of Interest

62%

Examples:

  • Lack of disclosure regarding potential conflicts of interest in reporting on meningitis vaccines.

Contradictions

86%

Examples:

  • Contradictions found in reporting on male birth control gel and prostate cancer diagnoses.
  • Misleading information about the link between climate change and dengue fever.

Deceptions

64%

Examples:

  • Deceptive practices found in reporting on PCOS and cognitive decline, and dengue fever.
  • Omission of key information about HIV risk for meningitis.

Recent Articles

Uncovering the Prevalence and Impacts of Long Covid: Insights from Leading Researchers and Policymakers

Uncovering the Prevalence and Impacts of Long Covid: Insights from Leading Researchers and Policymakers

Broke On: Tuesday, 09 July 2024 Long Covid, a condition marked by persistent symptoms for three months or more after initial infection, affects tens of millions worldwide. According to reports, approximately 7% of U.S. adults had suffered from it as of early 2023. Symptoms include fatigue, brain fog, and respiratory issues (CDC). Women and White/Hispanic individuals are more likely to be affected. One study found that one in ten people infected during pregnancy developed long Covid, with symptoms persisting for up to 10 months. Long Covid can lead to new behavioral health conditions or worsen pre-existing ones. Research is crucial for understanding causes and developing effective treatments.
USPSTF Shifts Focus: Behavioral Interventions for Childhood Obesity Over Medications

USPSTF Shifts Focus: Behavioral Interventions for Childhood Obesity Over Medications

Broke On: Tuesday, 18 June 2024 The US Preventive Services Task Force recommends comprehensive intensive behavioral interventions for children aged 6 and above with high BMI, rather than prescribing obesity medications. This shift is based on insufficient evidence on the benefits of pharmacotherapy for adolescents. The recommendations emphasize the importance of self-monitoring, goal-setting, supervised physical activity, and healthier eating habits as part of these interventions.
New Male Birth Control Gel Shows Promise in Clinical Trials: Effectively Reduces Sperm Production in 8 Weeks

New Male Birth Control Gel Shows Promise in Clinical Trials: Effectively Reduces Sperm Production in 8 Weeks

Broke On: Wednesday, 05 June 2024 A new hormonal gel for male birth control, which men apply on their shoulders, effectively reduces sperm production within eight weeks according to clinical trials. The rapid suppression of sperm makes it a significant advancement in male contraceptive options and an essential step towards gender equality.
Anger's Impact on Blood Vessels: A New Look at the Connection to Cardiovascular Diseases

Anger's Impact on Blood Vessels: A New Look at the Connection to Cardiovascular Diseases

Broke On: Wednesday, 01 May 2024 Anger's Impact on Cardiovascular Health: Recent studies reveal anger specifically impairs blood vessel dilation, increasing the risk of heart attacks and strokes. Recalling angry memories causes temporary impairment in blood vessel function for up to 40 minutes, while negative emotions like anxiety and sadness have no effect. Repeated episodes of anger may cause irreversible damage over time.
Former NIH Director Diagnosed with Aggressive Prostate Cancer, Encourages Early Detection and Participation in Clinical Trials

Former NIH Director Diagnosed with Aggressive Prostate Cancer, Encourages Early Detection and Participation in Clinical Trials

Broke On: Friday, 12 April 2024 Francis Collins, former director of the National Institutes of Health (NIH), has been diagnosed with aggressive prostate cancer and is undergoing a radical prostatectomy procedure. He uses his diagnosis to share lifesaving information about early detection and encourage participation in clinical trials for men at risk. Collins highlights health inequities faced by Black men, who are more likely to be diagnosed with aggressive forms of the disease. The conversation sparked by Collins' diagnosis emphasizes openness and transparency in healthcare, as well as continued research into effective treatment options.
CDC Alerts Health Care Providers of Rise in Bacterial Infections Caused by Meningococcus

CDC Alerts Health Care Providers of Rise in Bacterial Infections Caused by Meningococcus

Broke On: Sunday, 31 March 2024 The CDC has issued an alert to healthcare providers about a rise in bacterial infections caused by Neisseria meningitidis, also known as meningococcus. This condition can cause inflammation of the lining around your brain and spinal cord, leading to meningitis. There are six types of serogroups: A, B, C, W, X and Y. The four groups that affect the United States are B, C, W and Y.
Dengue Fever Surges in Latin America and the Caribbean: What You Need to Know

Dengue Fever Surges in Latin America and the Caribbean: What You Need to Know

Broke On: Saturday, 30 March 2024 Dengue fever, a mosquito-borne disease on the rise in Latin America and Caribbean with over 3.5 million cases reported as of March 26th including more than 100 deaths. Brazil accounts for most cases and deaths followed by Paraguay and Argentina due to higher transmission season in southern hemisphere when Aedes aegypti mosquitoes thrive. PAHO has issued nine epidemiological alerts since 2019 providing guidance on disease prevention and control, including information about all four dengue serotypes which increases the risk of severe forms.
PCOS Linked to Cognitive Decline in Midlife: Study Finds Women with Condition Score 11% Lower on Attention Ability Tests

PCOS Linked to Cognitive Decline in Midlife: Study Finds Women with Condition Score 11% Lower on Attention Ability Tests

Broke On: Wednesday, 31 January 2024 Recent studies have linked polycystic ovary syndrome (PCOS) with cognitive decline in midlife. Women with PCOS scored 11% lower on average compared to those without the condition when measuring attention ability and performed poorly on tests assessing memory, attention, and verbal abilities even after adjusting for age, race, and education. The exact causes of PCOS are still unknown but genetic factors may contribute to its development. It is important for women with PCOS to maintain a healthy lifestyle by having regular exercise routines that improve brain health such as cardiovascular exercises.